Schade AE / Mego / X5 / Pearson / Amler LC / Ford / Mani SA / Hess / Creative Commons / Philips / Donaldson / Anderson AE / /
Country
Greece / / /
Event
FDA Phase / /
Facility
University of Athens / Dam PA / University of Crete / /
IndustryTerm
tumor cell technology / analytical systems / cancer treatment / Online Publication / technology platforms / near-future applications / /
MedicalCondition
manifest metastasis / DF / chemotherapy-resistant residual disease / DCIS / mRNA-positive circulating tumor / BRITISH JOURNAL OF CANCER mRNA-positive / AdnaTest Breast Cancer / BRITISH JOURNAL OF CANCER CTC / primary breast cancer / early and metastatic breast cancer / spare breast cancer / overt metastasis / metastasis / early breast cancer / ductal carcinoma / metastatic and non-metastatic breast cancer / IL6 inflammatory loop / non-metastatic breast cancer / disseminated cancer / nonmetastatic breast cancer / metastatic disease / dormant cancer / Patients ER/PR-positive tumours / Complex tumor / breast cancer HER2 / metastatic breast cancer / lymphatic tumor / dormant disease / Riethdorf S. Cancer / systemic cancer / breast tumor / ER/PR-positive tumours / MS / luminal breast cancer / breast cancer / early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells / primary tumors / tumor / inflammatory loop / single circulating tumor / minimal residual disease / Cancer / colorectal carcinoma / disease / primary tumours / serum tumor / Disseminated tumor / III breast cancer / occult invasive tumours / late systemic cancer / progressive disease / hormonotherapy-resistant residual disease / node-negative breast cancer / tumour / BRITISH JOURNAL OF CANCER / Nat Rev Cancer / Only invasive cancers / HER2-positive circulating tumor / operable breast cancer / highly purified tumor / normal tumours / stable disease / minimal residual cancer / increased risk of late disease / breast cancer EPITHELIAL / Resistant cancer / HER2-positive metastatic breast cancer / metastases / cancer stem cell / distant metastases / tumours / individualized cancer / /
Lab of Analytical Chemistry / American Joint Committee on Cancer / Circulating Tumor Cells Lab / Department of Chemistry / University of Crete / Santos CR / University of Athens / /
Person
Van Haasteren V / Van Laere / Van Galen / Van Marck / Valero V / Ann Oncol / Van den Eynden / /
Position
driver / Butler / /
Product
CK-19mRNA / /
ProgrammingLanguage
C / /
ProvinceOrState
British Columbia / /
PublishedMedium
Analytical Chemistry / PLoS One / British Journal of Cancer / /
MINIREVIEW British Journal of Cancer (2013), 1–7 | doi: bjcKeywords: circulating tumour cells; CTC; liquid biopsy; micrometastasis; breast cancer; molecular characterisation